This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mooradian, D. L. Articles by Furcht, L. T. Search for Related Content PubMed PubMed Citation Articles by Mooradian, D. L. Articles by Furcht, L. T.

Differential Effects of Transforming Growth Factor ß1 on the Growth of Poorly and Highly Metastatic Murine Melanoma Cells¹

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota 55455 [D. L. M., L. T. F.], and Oncogen, Seattle, Washington 98121 [A. F. P.]

We have examined the effects of transforming growth factor ß1 (TGF-ß1) on the growth of paired murine melanoma cell clones that differ with respect to their experimental metastatic potential. Neither poorly (clone 16) nor highly (clone M2) metastatic cells were capable of anchorage-independent growth in 0.3% agar/Dulbecco's modified Eagle's medium in the absence of serum. However, both clones were capable of anchorage-independent growth in 0.3% agar/Dulbecco's modified Eagle's medium containing 10% calf serum. Colony formation in the presence of 10% calf serum was enhanced in a dose-dependent manner by TGF-ß1 (half-maximal dose, 0.1 ng/ml) and was 5- to 10-fold greater than colony formation in the presence of 10% calf serum alone. Under anchorage-dependent (monolayer) conditions, neither clone grew in the absence of serum or in medium containing less than 1% calf serum. The monolayer growth of poorly metastatic cells (clone 16) was enhanced in a dose-dependent manner by TGF-ß1 in medium supplemented with calf serum. Growth was 3.5-fold and 2.3-fold greater than untreated controls after 5 days in submitogenic (0.5%) and mitogenic (10%) concentrations of calf serum, respectively. In contrast, TGF-ß1 had no effect on the monolayer growth of highly metastatic cells (clone M2) either in submitogenic (0.5%) or mitogenic (10%) concentrations of serum. TGF-ß1 did not directly stimulate DNA synthesis by either poorly or highly metastatic cells when measured 24 h after TGF-ß1 treatment. The ability of TGF-ß1 to stimulate the anchorage-independent growth of metastatic melanoma cells suggests that this potent growth factor may play a role in the growth of these cells in vivo. In addition, the differential sensitivity of poorly and highly metastatic cells to TGF-ß1 may be relevant to their metastatic potential in vivo. While the mechanism(s) by which TGF-ß1 stimulates the growth of these cells remains unknown, these differentially metastatic clones of the K-1735 murine melanoma should provide a useful model in which to study the effects of transforming growth factor ß on the metastatic phenotype.

¹ This research was supported by NIH Grants CA21463 and CA29995 and a grant from the Leukemia Task Force.

² To whom requests for reprints should be addressed, at Department of Laboratory Medicine and Pathology, University of Minnesota, Box 609 Mayo Building UMHC, Minneapolis, MN 55455.

³ Allen-Pardee Professor of Cancer Biology.

Received 5/ 1/89. Revised 9/11/89. Accepted 10/10/89.

This article has been cited by other articles:

				Y. Maehara, Y. Kakeji, A. Kabashima, Y. Emi, A. Watanabe, K. Akazawa, H. Baba, S. Kohnoe, and K. Sugimachi Role of Transforming Growth Factor-{beta}1 in Invasion and Metastasis in Gastric Carcinoma J. Clin. Oncol., February 1, 1999; 17(2): 607 - 607. [Abstract] [Full Text] [PDF]

				M. Delcommenne and C. H. Streuli Control of Integrin Expression by Extracellular Matrix J. Biol. Chem., November 10, 1995; 270(45): 26794 - 26801. [Abstract] [Full Text] [PDF]

				A. Faassen, D. Mooradian, R. Tranquillo, R. Dickinson, P. Letourneau, T. Oegema, and J. McCarthy Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen J. Cell Sci., January 6, 1993; 105(2): 501 - 511. [Abstract] [PDF]